461 related articles for article (PubMed ID: 26196533)
1. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis.
Fitzgerald KA; Guo J; Raftery RM; Castaño IM; Curtin CM; Gooding M; Darcy R; O' Brien FJ; O' Driscoll CM
Int J Pharm; 2016 Sep; 511(2):1058-69. PubMed ID: 27492023
[TBL] [Abstract][Full Text] [Related]
3. Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.
Evans JC; Malhotra M; Fitzgerald KA; Guo J; Cronin MF; Curtin CM; O'Brien FJ; Darcy R; O'Driscoll CM
Mol Pharm; 2017 Jan; 14(1):42-52. PubMed ID: 28043128
[TBL] [Abstract][Full Text] [Related]
4. A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.
Curtin C; Nolan JC; Conlon R; Deneweth L; Gallagher C; Tan YJ; Cavanagh BL; Asraf AZ; Harvey H; Miller-Delaney S; Shohet J; Bray I; O'Brien FJ; Stallings RL; Piskareva O
Acta Biomater; 2018 Apr; 70():84-97. PubMed ID: 29447961
[TBL] [Abstract][Full Text] [Related]
5. Behavior of prostate cancer cells in a nanohydroxyapatite/collagen bone scaffold.
Cruz-Neves S; Ribeiro N; Graça I; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Mater Res A; 2017 Jul; 105(7):2035-2046. PubMed ID: 28371333
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.
Bonfil RD; Dong Z; Trindade Filho JC; Sabbota A; Osenkowski P; Nabha S; Yamamoto H; Chinni SR; Zhao H; Mobashery S; Vessella RL; Fridman R; Cher ML
Am J Pathol; 2007 Jun; 170(6):2100-11. PubMed ID: 17525276
[TBL] [Abstract][Full Text] [Related]
7. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.
Podgorski I; Linebaugh BE; Sameni M; Jedeszko C; Bhagat S; Cher ML; Sloane BF
Neoplasia; 2005 Mar; 7(3):207-23. PubMed ID: 15799821
[TBL] [Abstract][Full Text] [Related]
8. 3D cell culture and osteogenic differentiation of human bone marrow stromal cells plated onto jet-sprayed or electrospun micro-fiber scaffolds.
Brennan MÁ; Renaud A; Gamblin AL; D'Arros C; Nedellec S; Trichet V; Layrolle P
Biomed Mater; 2015 Aug; 10(4):045019. PubMed ID: 26238732
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
10. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis.
Sieh S; Taubenberger AV; Lehman ML; Clements JA; Nelson CC; Hutmacher DW
Bone; 2014 Jun; 63():121-31. PubMed ID: 24530694
[TBL] [Abstract][Full Text] [Related]
11. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
12. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.
Takeshita F; Minakuchi Y; Nagahara S; Honma K; Sasaki H; Hirai K; Teratani T; Namatame N; Yamamoto Y; Hanai K; Kato T; Sano A; Ochiya T
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12177-82. PubMed ID: 16091473
[TBL] [Abstract][Full Text] [Related]
13. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
14. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
Hall CL; Dai J; van Golen KL; Keller ET; Long MW
Cancer Res; 2006 Sep; 66(17):8648-54. PubMed ID: 16951179
[TBL] [Abstract][Full Text] [Related]
15. [Role and action mechanisms of FZD5 in prostate cancer bone metastasis in mice].
Zhang X; Mo QW
Zhonghua Nan Ke Xue; 2016 Feb; 22(2):128-32. PubMed ID: 26939396
[TBL] [Abstract][Full Text] [Related]
16. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
Subia B; Dey T; Sharma S; Kundu SC
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
[TBL] [Abstract][Full Text] [Related]
18. Heralding a new paradigm in 3D tumor modeling.
Fong EL; Harrington DA; Farach-Carson MC; Yu H
Biomaterials; 2016 Nov; 108():197-213. PubMed ID: 27639438
[TBL] [Abstract][Full Text] [Related]
19. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
Matsubara S; Wada Y; Gardner TA; Egawa M; Park MS; Hsieh CL; Zhau HE; Kao C; Kamidono S; Gillenwater JY; Chung LW
Cancer Res; 2001 Aug; 61(16):6012-9. PubMed ID: 11507044
[TBL] [Abstract][Full Text] [Related]
20. Bioengineered Microtissue Models of the Human Bone Metastatic Microenvironment: A Novel In Vitro Theranostics Platform for Cancer Research.
Bock N
Methods Mol Biol; 2019; 2054():23-57. PubMed ID: 31482446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
